Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 28 | 2023 | 20817 | 1.770 |
Why?
|
Career Mobility | 4 | 2020 | 262 | 1.180 |
Why?
|
Early Detection of Cancer | 10 | 2023 | 3086 | 1.010 |
Why?
|
Faculty, Medical | 4 | 2017 | 1181 | 0.940 |
Why?
|
Spirituality | 5 | 2023 | 405 | 0.740 |
Why?
|
Mammography | 9 | 2023 | 2477 | 0.730 |
Why?
|
Pamphlets | 1 | 2020 | 75 | 0.710 |
Why?
|
Health Occupations | 1 | 2020 | 224 | 0.670 |
Why?
|
Education, Distance | 1 | 2022 | 251 | 0.650 |
Why?
|
Biomedical Research | 3 | 2020 | 3311 | 0.630 |
Why?
|
Cultural Diversity | 1 | 2020 | 359 | 0.590 |
Why?
|
Health Literacy | 1 | 2022 | 414 | 0.580 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13096 | 0.540 |
Why?
|
Awareness | 1 | 2019 | 640 | 0.500 |
Why?
|
Telomere | 1 | 2020 | 910 | 0.490 |
Why?
|
Reproductive History | 2 | 2023 | 209 | 0.480 |
Why?
|
Adiposity | 2 | 2021 | 1807 | 0.470 |
Why?
|
Financing, Government | 1 | 2017 | 468 | 0.470 |
Why?
|
Breast | 5 | 2023 | 1969 | 0.450 |
Why?
|
Community Health Centers | 2 | 2013 | 428 | 0.440 |
Why?
|
Research Support as Topic | 1 | 2017 | 704 | 0.440 |
Why?
|
Patient Education as Topic | 2 | 2020 | 2277 | 0.430 |
Why?
|
Leukocytes | 1 | 2020 | 2040 | 0.420 |
Why?
|
Socioeconomic Factors | 6 | 2022 | 7784 | 0.420 |
Why?
|
Academic Medical Centers | 3 | 2017 | 2759 | 0.390 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2732 | 0.390 |
Why?
|
Female | 57 | 2023 | 380197 | 0.350 |
Why?
|
Communication | 4 | 2021 | 3749 | 0.350 |
Why?
|
Smoking Cessation | 1 | 2021 | 2071 | 0.350 |
Why?
|
Premenopause | 1 | 2013 | 1033 | 0.340 |
Why?
|
Body Mass Index | 8 | 2023 | 12718 | 0.330 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1076 | 0.330 |
Why?
|
Middle Aged | 41 | 2023 | 213367 | 0.330 |
Why?
|
Health Status Disparities | 3 | 2023 | 1797 | 0.320 |
Why?
|
Physicians | 2 | 2023 | 4564 | 0.320 |
Why?
|
Reproduction | 1 | 2013 | 668 | 0.310 |
Why?
|
Publishing | 1 | 2015 | 833 | 0.310 |
Why?
|
Obesity | 7 | 2021 | 12742 | 0.310 |
Why?
|
Self Report | 4 | 2022 | 3558 | 0.310 |
Why?
|
Humans | 69 | 2024 | 744220 | 0.300 |
Why?
|
Gout | 2 | 2023 | 573 | 0.270 |
Why?
|
United States | 20 | 2023 | 69867 | 0.270 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3227 | 0.260 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.250 |
Why?
|
Overweight | 1 | 2016 | 2370 | 0.250 |
Why?
|
Boston | 4 | 2023 | 9311 | 0.250 |
Why?
|
Social Class | 3 | 2022 | 1999 | 0.250 |
Why?
|
Adult | 34 | 2023 | 214035 | 0.250 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1432 | 0.250 |
Why?
|
Religion | 3 | 2023 | 356 | 0.240 |
Why?
|
Hypertension | 5 | 2023 | 8480 | 0.240 |
Why?
|
Patient Participation | 1 | 2013 | 1457 | 0.230 |
Why?
|
Aged | 27 | 2023 | 163253 | 0.230 |
Why?
|
Nurses | 1 | 2013 | 2461 | 0.220 |
Why?
|
Mass Screening | 3 | 2022 | 5252 | 0.220 |
Why?
|
Urban Population | 1 | 2010 | 2021 | 0.210 |
Why?
|
Neoplasms | 4 | 2024 | 21672 | 0.210 |
Why?
|
Ontario | 1 | 2022 | 383 | 0.200 |
Why?
|
Patient Selection | 2 | 2013 | 4216 | 0.200 |
Why?
|
Residence Characteristics | 1 | 2010 | 2050 | 0.180 |
Why?
|
Communicable Disease Control | 2 | 2023 | 857 | 0.170 |
Why?
|
Hyperuricemia | 1 | 2022 | 211 | 0.170 |
Why?
|
Educational Status | 3 | 2021 | 2539 | 0.170 |
Why?
|
Masks | 1 | 2021 | 197 | 0.170 |
Why?
|
Prospective Studies | 12 | 2022 | 53280 | 0.160 |
Why?
|
Exercise | 2 | 2012 | 5615 | 0.160 |
Why?
|
Neoplasm Staging | 6 | 2023 | 11007 | 0.160 |
Why?
|
Pandemics | 7 | 2022 | 8387 | 0.160 |
Why?
|
Adaptation, Psychological | 4 | 2023 | 2576 | 0.160 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 25043 | 0.160 |
Why?
|
Diphosphonates | 1 | 2022 | 624 | 0.150 |
Why?
|
Pilot Projects | 3 | 2020 | 8321 | 0.150 |
Why?
|
Logistic Models | 5 | 2016 | 13409 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 252 | 0.150 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 703 | 0.150 |
Why?
|
Weight Loss | 4 | 2013 | 2622 | 0.150 |
Why?
|
Arteritis | 1 | 2019 | 159 | 0.150 |
Why?
|
Computers | 1 | 2020 | 611 | 0.150 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2023 | 2017 | 0.150 |
Why?
|
Contraceptives, Oral | 2 | 2023 | 563 | 0.140 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2016 | 30 | 0.140 |
Why?
|
Comprehension | 1 | 2022 | 610 | 0.140 |
Why?
|
Proportional Hazards Models | 4 | 2016 | 12355 | 0.140 |
Why?
|
Receptors, Estrogen | 2 | 2016 | 2186 | 0.140 |
Why?
|
Health Services Needs and Demand | 2 | 2023 | 1411 | 0.140 |
Why?
|
Internet | 2 | 2022 | 3063 | 0.140 |
Why?
|
Social Justice | 1 | 2020 | 456 | 0.140 |
Why?
|
Young Adult | 9 | 2022 | 56436 | 0.140 |
Why?
|
Amygdala | 2 | 2023 | 1315 | 0.130 |
Why?
|
Social Stigma | 1 | 2021 | 701 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 3923 | 0.130 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6893 | 0.130 |
Why?
|
Incidence | 5 | 2019 | 20945 | 0.120 |
Why?
|
Smoking | 2 | 2023 | 8986 | 0.120 |
Why?
|
Quality of Life | 4 | 2023 | 12805 | 0.120 |
Why?
|
Male | 24 | 2023 | 350027 | 0.120 |
Why?
|
Schools, Medical | 2 | 2017 | 878 | 0.120 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 780 | 0.120 |
Why?
|
Cohort Studies | 4 | 2023 | 40559 | 0.110 |
Why?
|
Organizational Culture | 1 | 2017 | 510 | 0.110 |
Why?
|
Awards and Prizes | 1 | 2017 | 375 | 0.110 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 12264 | 0.110 |
Why?
|
Research Personnel | 1 | 2017 | 573 | 0.110 |
Why?
|
Efficiency | 1 | 2015 | 462 | 0.100 |
Why?
|
Mentors | 1 | 2017 | 630 | 0.100 |
Why?
|
Stress, Psychological | 2 | 2019 | 4245 | 0.100 |
Why?
|
Age of Onset | 3 | 2016 | 3270 | 0.100 |
Why?
|
Risk Factors | 9 | 2023 | 72280 | 0.100 |
Why?
|
Melatonin | 1 | 2016 | 721 | 0.100 |
Why?
|
Physicians, Women | 1 | 2017 | 486 | 0.090 |
Why?
|
Menarche | 1 | 2013 | 516 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39045 | 0.090 |
Why?
|
Demography | 1 | 2015 | 1656 | 0.090 |
Why?
|
Acidosis, Lactic | 1 | 1992 | 142 | 0.090 |
Why?
|
Parity | 1 | 2013 | 929 | 0.090 |
Why?
|
Perception | 1 | 2017 | 1198 | 0.090 |
Why?
|
Body Height | 1 | 2016 | 1576 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.090 |
Why?
|
Patient Satisfaction | 2 | 2020 | 3395 | 0.090 |
Why?
|
Health Promotion | 1 | 2021 | 2205 | 0.080 |
Why?
|
Family Characteristics | 1 | 2014 | 1000 | 0.080 |
Why?
|
Nutrition Surveys | 3 | 2023 | 1660 | 0.080 |
Why?
|
Age Factors | 3 | 2016 | 18367 | 0.080 |
Why?
|
Women's Health | 2 | 2021 | 2034 | 0.080 |
Why?
|
Physical Fitness | 1 | 2013 | 733 | 0.080 |
Why?
|
Delivery of Health Care | 2 | 2024 | 5319 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2208 | 0.080 |
Why?
|
Actigraphy | 1 | 2012 | 488 | 0.080 |
Why?
|
Receptors, Progesterone | 1 | 2013 | 1097 | 0.080 |
Why?
|
Internal Medicine | 1 | 2015 | 1009 | 0.080 |
Why?
|
Urban Health | 1 | 2010 | 547 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 7908 | 0.080 |
Why?
|
Time Factors | 3 | 2015 | 40063 | 0.080 |
Why?
|
Neurology | 1 | 2015 | 764 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9230 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2023 | 57768 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3216 | 0.070 |
Why?
|
Self Care | 1 | 2012 | 786 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2416 | 0.070 |
Why?
|
Vulnerable Populations | 1 | 2012 | 686 | 0.070 |
Why?
|
California | 1 | 2010 | 1402 | 0.070 |
Why?
|
Behavior Therapy | 1 | 2012 | 867 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2790 | 0.070 |
Why?
|
Genetic Testing | 1 | 1999 | 3443 | 0.070 |
Why?
|
Sex Factors | 2 | 2017 | 10396 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 2 | 2016 | 3023 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2016 | 2726 | 0.070 |
Why?
|
Anesthesiology | 1 | 2015 | 1049 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1677 | 0.060 |
Why?
|
Health Behavior | 2 | 2021 | 2636 | 0.060 |
Why?
|
Self Concept | 1 | 2011 | 1025 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 15525 | 0.060 |
Why?
|
Odds Ratio | 2 | 2016 | 9849 | 0.060 |
Why?
|
Primary Health Care | 2 | 2012 | 4556 | 0.060 |
Why?
|
Cause of Death | 1 | 2015 | 3584 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3158 | 0.060 |
Why?
|
Program Evaluation | 1 | 2013 | 2486 | 0.060 |
Why?
|
Risk Assessment | 3 | 2023 | 23337 | 0.060 |
Why?
|
General Surgery | 1 | 2015 | 1636 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12244 | 0.060 |
Why?
|
Lung | 1 | 2022 | 9852 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10250 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.060 |
Why?
|
Energy Intake | 1 | 2011 | 2148 | 0.060 |
Why?
|
Psychiatry | 1 | 2015 | 1695 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3222 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3888 | 0.050 |
Why?
|
Child | 3 | 2020 | 77679 | 0.050 |
Why?
|
Adolescent | 3 | 2020 | 85759 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2053 | 0.050 |
Why?
|
Social Marketing | 1 | 2021 | 52 | 0.050 |
Why?
|
Radiology | 1 | 2015 | 2099 | 0.050 |
Why?
|
Risk | 1 | 2013 | 9685 | 0.050 |
Why?
|
Poverty | 1 | 2013 | 2660 | 0.050 |
Why?
|
Ifosfamide | 2 | 1992 | 228 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2016 | 63119 | 0.050 |
Why?
|
Pediatrics | 1 | 2015 | 3469 | 0.050 |
Why?
|
Anthracyclines | 1 | 2022 | 288 | 0.050 |
Why?
|
Eligibility Determination | 1 | 2023 | 403 | 0.040 |
Why?
|
Prognosis | 3 | 2023 | 29050 | 0.040 |
Why?
|
Etoposide | 2 | 1992 | 639 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11074 | 0.040 |
Why?
|
Medicaid | 1 | 2012 | 2736 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13668 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2021 | 553 | 0.040 |
Why?
|
Cultural Competency | 1 | 2021 | 289 | 0.040 |
Why?
|
Canada | 2 | 2020 | 2065 | 0.040 |
Why?
|
Public Health | 2 | 2021 | 2603 | 0.040 |
Why?
|
Pregnancy | 2 | 2023 | 29142 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11732 | 0.040 |
Why?
|
Uric Acid | 1 | 2023 | 765 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 1999 | 17449 | 0.040 |
Why?
|
Survival Rate | 2 | 2010 | 12781 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2016 | 93 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15161 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20123 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2016 | 918 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 1999 | 781 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15226 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2019 | 21752 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 547 | 0.030 |
Why?
|
Health Communication | 1 | 2018 | 214 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 1992 | 5221 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
Massachusetts | 2 | 2018 | 8663 | 0.030 |
Why?
|
Cisplatin | 2 | 1992 | 1642 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 553 | 0.030 |
Why?
|
Creatine | 1 | 2016 | 421 | 0.030 |
Why?
|
Research Design | 1 | 2010 | 5987 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1223 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 1992 | 6352 | 0.030 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 350 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19907 | 0.030 |
Why?
|
Social Perception | 1 | 2017 | 424 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2023 | 2662 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2017 | 535 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 1992 | 11493 | 0.030 |
Why?
|
Prejudice | 1 | 2017 | 570 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 2478 | 0.030 |
Why?
|
Medical Oncology | 1 | 2024 | 2265 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2019 | 13990 | 0.030 |
Why?
|
Menopause | 1 | 2019 | 1626 | 0.030 |
Why?
|
Therapy, Computer-Assisted | 1 | 2014 | 277 | 0.030 |
Why?
|
Body Weight | 1 | 2021 | 4666 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3528 | 0.020 |
Why?
|
Paraneoplastic Syndromes | 1 | 1992 | 150 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2019 | 2069 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1990 | 637 | 0.020 |
Why?
|
Telephone | 1 | 2012 | 617 | 0.020 |
Why?
|
Neutropenia | 2 | 1992 | 895 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3019 | 0.020 |
Why?
|
Postmenopause | 1 | 2016 | 2461 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3921 | 0.020 |
Why?
|
Leadership | 1 | 2017 | 1357 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4289 | 0.020 |
Why?
|
Thinness | 1 | 2011 | 479 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2013 | 1682 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6274 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 1999 | 3703 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2012 | 681 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2014 | 1424 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2010 | 1462 | 0.020 |
Why?
|
Counseling | 1 | 2012 | 1523 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5076 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4982 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 77426 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11368 | 0.010 |
Why?
|
Transcription Factors | 1 | 1999 | 12207 | 0.010 |
Why?
|
District of Columbia | 1 | 1999 | 157 | 0.010 |
Why?
|
Founder Effect | 1 | 1999 | 190 | 0.010 |
Why?
|
Algorithms | 1 | 1999 | 13885 | 0.010 |
Why?
|
Jews | 1 | 1999 | 385 | 0.010 |
Why?
|
Blood Pressure | 1 | 2012 | 8551 | 0.010 |
Why?
|
Mutation | 1 | 1999 | 29784 | 0.010 |
Why?
|
BRCA2 Protein | 1 | 1999 | 794 | 0.010 |
Why?
|
Family Health | 1 | 1999 | 1282 | 0.010 |
Why?
|
Heterozygote | 1 | 1999 | 2805 | 0.010 |
Why?
|
Diet | 1 | 2011 | 7937 | 0.010 |
Why?
|
Gene Frequency | 1 | 1999 | 3588 | 0.010 |
Why?
|
Agranulocytosis | 1 | 1992 | 100 | 0.010 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 1992 | 628 | 0.010 |
Why?
|
Vomiting | 1 | 1992 | 635 | 0.010 |
Why?
|
Remission Induction | 1 | 1992 | 2389 | 0.000 |
Why?
|
Bone Marrow | 1 | 1992 | 2944 | 0.000 |
Why?
|
Concepts
(267)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(86)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_